Large-scale testing (Phase 3)Study completedNCT00240695
What this trial is testing
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
Who this might be right for
Cognition DisorderNervous System DiseasesMental Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 724